BridgeBio Pharma, Inc. (BBIO)

65.36 -0.81 (-1.22%) USD  |  NASDAQ  |  Mar 06, 16:00
65.32 -0.04 (-0.06%) After-Hours: 20:00
More

BridgeBio Pharma Payables and Accrued Expenses (Quarterly)

Payables and Accrued Expenses (Quarterly) Chart

View Payables and Accrued Expenses (Quarterly) for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Payables and Accrued Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Payables and Accrued Expenses (Quarterly) Range, Past 5 Years

View Payables and Accrued Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Payables and Accrued Expenses (Quarterly) Benchmarks

View Payables and Accrued Expenses (Quarterly) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade
Alphatec Holdings, Inc. Upgrade
Supernus Pharmaceuticals, Inc. Upgrade
Cogent Biosciences, Inc. Upgrade